Login to Your Account



Another Acquisition for Takeda; Buying URL Pharma for $800M

By Catherine Shaffer
Staff Writer

Thursday, April 12, 2012
Four months after acquiring Intellikine Inc. for $320 million, and less than a year after its major purchase of Nycomed GmbH for $13.7 billion, Takeda Pharmaceutical Co. Ltd. said it will add another new asset to its portfolio.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription